NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 123 filers reported holding NATERA INC in Q4 2018. The put-call ratio across all filers is 22.29 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $11,432,000 | +103.5% | 554,432 | +37.8% | 0.01% | +75.0% |
| Q4 2018 | $5,618,000 | -67.2% | 402,453 | -43.8% | 0.01% | -20.0% |
| Q3 2018 | $17,130,000 | +1477.3% | 715,514 | +1139.8% | 0.01% | +900.0% |
| Q2 2018 | $1,086,000 | +108.0% | 57,710 | +2.5% | 0.00% | 0.0% |
| Q1 2018 | $522,000 | +2.4% | 56,320 | -0.8% | 0.00% | 0.0% |
| Q4 2017 | $510,000 | -41.5% | 56,778 | -16.1% | 0.00% | 0.0% |
| Q3 2017 | $872,000 | +43.7% | 67,683 | +21.1% | 0.00% | 0.0% |
| Q2 2017 | $607,000 | +54.5% | 55,907 | +26.1% | 0.00% | 0.0% |
| Q1 2017 | $393,000 | -24.1% | 44,348 | +0.3% | 0.00% | 0.0% |
| Q4 2016 | $518,000 | +10.7% | 44,224 | +5.0% | 0.00% | 0.0% |
| Q3 2016 | $468,000 | -7.9% | 42,108 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $508,000 | +388.5% | 42,108 | +286.0% | 0.00% | – |
| Q1 2016 | $104,000 | -11.9% | 10,908 | 0.0% | 0.00% | – |
| Q4 2015 | $118,000 | 0.0% | 10,908 | 0.0% | 0.00% | – |
| Q3 2015 | $118,000 | – | 10,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |